Literature DB >> 26732655

[Many faces of sarcoidosis].

H Prosch1, K Vonbank2, C Loewe3, D Beitzke3.   

Abstract

Sarcoidosis is a systemic, inflammatory, granulomatous disease of unknown origin that can involve any organ. More than 90% of patients have thoracic sarcoidosis, which most frequently presents with bilateral hilar lymphadenopathy. In approximately 20% of patients with thoracic sarcoidosis there is involvement of the lung parenchyma as well as mostly asymptomatic cardiac sarcoidosis in up to 55% of patients. Most patients are asymptomatic and the diagnosis is an incidental finding on chest X-ray or during clarification of unspecific symptoms, such as fatigue or cough. In approximately two thirds of patients the disease undergoes spontaneous remission and in one third the disease follows a chronic or even progressive course. Furthermore, sarcoidosis can also be manifested in the abdominal organs, the central nervous system (CNS) and the musculoskeletal system. These manifestations are frequently subclinical and require targeted diagnostics when sarcoidosis is clinically suspected.

Entities:  

Keywords:  Computed tomography; Granuloma; Inflammation; Lymphadenopathy; Systemic disease

Mesh:

Year:  2016        PMID: 26732655     DOI: 10.1007/s00117-015-0063-9

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  27 in total

Review 1.  The protean face of renal sarcoidosis.

Authors:  Ursula Göbel; Ralph Kettritz; Wolfgang Schneider; Friedrich C Luft
Journal:  J Am Soc Nephrol       Date:  2001-03       Impact factor: 10.121

Review 2.  Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation.

Authors:  Eva Criado; Marcelo Sánchez; José Ramírez; Pedro Arguis; Teresa M de Caralt; Rosario J Perea; Antonio Xaubet
Journal:  Radiographics       Date:  2010-10       Impact factor: 5.333

3.  High-resolution CT findings of pulmonary sarcoidosis.

Authors:  Z C Traill; G F Maskell; F V Gleeson
Journal:  AJR Am J Roentgenol       Date:  1997-06       Impact factor: 3.959

4.  An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study.

Authors:  Simon Lf Walsh; Athol U Wells; Nicola Sverzellati; Gregory J Keir; Lucio Calandriello; Katerina M Antoniou; Susan J Copley; Anand Devaraj; Toby M Maher; Elizabetta Renzoni; Andrew G Nicholson; David M Hansell
Journal:  Lancet Respir Med       Date:  2014-01-15       Impact factor: 30.700

5.  Ground-glass attenuation, nodules, alveolitis, and sarcoid granulomas.

Authors:  N L Müller; R R Miller
Journal:  Radiology       Date:  1993-10       Impact factor: 11.105

Review 6.  Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

Review 7.  Neurosarcoidosis: diagnosis and management.

Authors:  Diana L Vargas; Barney J Stern
Journal:  Semin Respir Crit Care Med       Date:  2010-07-27       Impact factor: 3.119

8.  Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. I. Sarcoidosis.

Authors:  M Sekiguchi; Y Numao; M Imai; T Furuie; R Mikami
Journal:  Jpn Circ J       Date:  1980-04

9.  [MRI in cardiac sarcoidosis and amyloidosis].

Authors:  K U Bauner; B Wintersperger
Journal:  Radiologe       Date:  2013-01       Impact factor: 0.635

Review 10.  Clinical presentation of sarcoidosis and diagnostic work-up.

Authors:  Dominique Valeyre; Jean-François Bernaudin; Yurdagul Uzunhan; Marianne Kambouchner; Pierre-Yves Brillet; Michael Soussan; Hilario Nunes
Journal:  Semin Respir Crit Care Med       Date:  2014-07-09       Impact factor: 3.119

View more
  1 in total

Review 1.  [Sarcoidosis and uveitis : An update].

Authors:  J G Garweg
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.